2016 EVENT REVIEWS

See what last year's delegates had to day

2017 PRELIMINARY AGENDA
REGISTER TODAY

Previous Event Partners and Supporters

EVENT TESTIMONIALS

PETER GEORGE

Nathan Tinker

CEO, NewYorkBIO

"The right people in the right place at the right time. New York is on the verge of exploding and this is the conference that puts all the pieces together"

PETER GEORGE

Terence Lippert

Senior, Intralinks

“ A lot of positive feedback! Terrific brand recognition. We also had loads of people requesting free access to the portal we’re marketing here today ”.

Yuval Cohen

Yuval Cohen

CEO, Corbus Pharma

“ The star power – with people like Jeremy Levin, Deerfield, Spark Therapeutics etc. was a real draw. The discussions I heard were very informative – I learned quite a few new things. The networking opportunity was also really above my expectations. Very pleasantly surprised. That was very powerful. Looking forward to the next one! Outstanding ”.

PETER GEORGE

Louise Tiranoff

CEO, GeneticaLens

“ I now have appointments and a great opportunity to work with a new partner on this big pilot we are planning. The learning about fund raising was also great. This was a great environment for that”.

PETER GEORGE

Nick Green

Managing Partner, Coulter Partners

“ The networking, meeting people informally outside of the panel sessions, was particularly useful ”.

PETER GEORGE

Frank Minella

Founder, PainQx

“ The most valuable thing for me are the contacts from the 1 on 1 partnering meetings. We are expecting follow on opportunities from those initial contacts”.

PETER GEORGE

John Jennings

Associate, Harter, Secrest and Emery

“ The first session about why biotech in New York, what could be done better, what has been a success. I think that was very valuable”.

PETER GEORGE

Shai Biran

Post Doctoral Researcher, The Weizmann Institute

“ Organized well. I particularly enjoed interesting panels plus there was lots of opportunity for networking! ”.

PETER GEORGE

Bill Harvey

Managing Director, Newmark Grubb Knight Frank

“ Great speakers and topics! ”.

PETER GEORGE

Mark Punyanitya

Founder & CEO, MagnePath USA, Inc.

“ Attracting very high level speakers and facilitating engagement and interactions. I thoroughly enjoyed direct access to important attendees via 1-on-1 partnering meetings and additional key opinion leaders via the engaging panel and roundtable sessions”.

PETER GEORGE

Dan Conley

Active Angel investor, Angels & LifeSci Energy Investors Networks

“ Good focus on money, with candid tidbits of what investors are REALLY looking for. Great networking too.”.

PETER GEORGE

Sergei Petukhov

Partner, Enso Ventures

“What this congress does really well is 1X1 meetings”.

PETER GEORGE

Nicole Littrean

Senior Director, Corporate Sponsorships, The New York Stem Cell Foundation

“Great keynotes from fantastic organizations, small, big and emerging. Great content and speakers”.

PETER GEORGE

Cyndi Green

Senior Director, Business Development, Pfizer

“ Nice, broad mix of speakers and good networking. A good local conference for me!”.

PETER GEORGE

Carlos N Velez

Partner, Ventac Partners

“Roundtables are a terrific idea. More, please. ”

PETER GEORGE

Andrew Koopman

Director of New Ventures, New York University

“It was the right size for effectively connecting and interacting with members of the biotech community.”

PETER GEORGE

M. Umit Uyar

Professor, City College of New York, CUNY

“ Brings people together in an informal way. Met many important people otherwise I would not have met. ”

PETER GEORGE

Roman Rohrberg

Manager, Investment and Expansion, Bavarian U.S. Office for Economic Development

“ I made very good connections to companies!”.

PETER GEORGE

Lawrence Bloch

CFO & CBO, Infinity Pharmaceuticals

“ Good selection of moderators, panelists and topics ”.

PETER GEORGE

Eugene Mancino

Partner, Mancino Burfield Edgerton

“The blend of science and commercial thinking was excellent. The speakers were able to speak about relevant topics in the life sciences industry in an objective and well informed manner.”

PETER GEORGE

Nelson Scharadin

CEO, Mitogen

“ Very effectively communicate all the issues surrounding how an early-stage company obtains funding and what obstacles lie in the path to overcome. Speakers were extremely well versed in the real problems affecting early-stage companies. What can take years to amass in terms of what and how to do it, is communicated to you in a few hours.”

PETER GEORGE

Michael G. King Jr.

Managing Director, JMP Securities

“Brought in some very cool players from the pharma industry. Met a lot of great people from the local area.”

PETER GEORGE

Shyam Parekh

Business Development Manager, Halyard Health

“ Great event to network with NYC local area industry participants.”

PETER GEORGE

Ray Lee

Analyst, Sphera Fund

“ The highlight for me was VC and big pharma business development people sharing their policy .”

PETER GEORGE

Kristen Kosofsky

Senior Managing Director, Hercules Technology Growth Capital

“ This was a great conference with the appropriate amount of investors, companies and other inter- ested sector players that allowed networking and learning opportunities.”